Synthetic Biology Market: Global industry analysis and forecast 2016-2024

Synthetic Biology Market - Global Industry Insights,
Trends and Opportunity Analysis, 2016-2024
[Company address]
Report Description
Synthetic biology is a combination of biology and biomedical engineering principles that favors designing
and construction of novel biological parts & systems and also the reconstruction of preexisting designs
according to specific application requirements. Synthetic biology is extensively used in the field of medical
and pharmaceuticals to produce and manufacture improved biological drugs and systems to meet various
challenges in the healthcare sector.
Synthetic biology offers various opportunities in the field of healthcare such as recreating highly complex
pathways, DNA sequences, and natural biological systems. In synthetic biology market, genetically
modified organisms is the new approach for researchers. However, currently only one engineered gene
has been developed, with increasing focus on creating clusters of genes. Also, due to the rising demand
for vaccines in high income countries, synthetic biologists are more inclined towards research of various
types of vaccines that can be used as prophylaxis. According to WHO, in in 2011, high income countries
such as the U.S., Japan, and the U.K. contributed around 80% of global vaccine sales revenue, with these
regions accounting for 20% volume share.
Request for Complete TOC before buying this exclusive Report by CMI:
Synthetic biology market taxonomy:
By Product Type
Synthetic DNA
Synthetic cells
Synthetic genes
Chassis organisms
Genetically modified organisms
Oligonucleotide Synthesis
By Tool
Xeno-nucleic Acids (XNA)
Cloning and Assembly kits
By Technology
Enabling Technologies
Site-saturation Mutagenesis
Measurement and Modeling
Cloning and Sequencing
Gene Synthesis
Genome Engineering
Enabled Technologies
Pathway Engineering
Next-generation Sequencing
By Application
Environmental Application
Whole-cell Biosensors
Industrial Application
Biofuels and Renewable Energy
Industrial Enzymes
Biomaterials and Green Chemicals
Medical Application
Artificial Tissue and Tissue Regeneration
Drug Discovery and Therapeutics
Government funding supporting synthetic biology market growth:
Growing demand for synthetic biology products such as synthetic DNA, synthetic genes for treatment of
diseases and for developing genetic modified products such as hybrid crop, genetically modified animals
for enhancing the nutritional value of the food is also contributing towards the growth of the synthetic
biology market. Also, various governments are investing in research and development of novel synthetic
biology products. For instance, according to the report from U.S. Trends in Synthetic Biology Research at
the Wilson Center, during the period of six years from 2008 to 2014, the U.S. invested around US$ 820
million in research for products in synthetic biology. Among different funding agencies, the defense
department became a key funder of synthetic biology research dominating the funds by national science
foundation. The above key fact also suggests that U.S. is expected to be a significant contributor in
synthetic biology market.
Get More Details About This Report @
Regional analysis of synthetic biology market:
Developed countries such as the U.S., Germany, U.K., France, and Japan have mature markets for
synthetic biology mainly due to large funding and favorable government regulation regarding the approval
of synthetic biology products. According to genetic engineering & biotechnology news in 2010, the
government of three European countries namely the Netherlands, U.K., and Germany invested around
US$ 160 million in a span of five years between 2005 and 2010. Regulations such as Toxic Substances
Control Act (TSCA) in 1997, cover commercial uses of new microorganisms not regulated by other
agencies: primary rules covering industrial biotechnology. European Commission and research agencies
have also increased their funding for research in synthetic biology. In emerging economies in Asia-Pacific,
Middle East, and Africa, governments are focusing on tackling major issues such as under-nutrition by
encouraging adoption of GMO crops. For example, Indian government is had put efforts in the past
regarding in terms of intervention programs to combat malnutrition such as Integrated child development
services and mid-day meal program This creates a highly conducive environment for market growth.
Major acquisitions to support the growth in synthetic biology market
There are few recent acquisitions by the big brands in biotechnology that is expected to favor the market
for synthetic biology. QIAGEN N.V acquired OmicSoft—a software solutions company that offers scientists
and researchers tools to efficiently analyze and visualize the data in bioinformatics. This acquisition is
further expected to favor the working efficiency of the company. Key players operating in the synthetic
biology market include DuPont, Amyris, Inc., GenScript USA Inc., Integrated DNA Technologies, Intrexon
Corporation, New England Biolabs, Inc., Thermo Fisher Scientific, Inc., Synthetic Genomics, Inc., Royal
DSM, and Novozymes.
About Us
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting
our plethora of clients achieve transformational growth by helping them make critical business decisions.
We are headquartered in India, having office at global financial capital in the U.S. Our client base includes
players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to
help businesses around the globe deliver practical and lasting results through various recommendations
about operational improvements, technologies, emerging market trends and new working methods. We
offer both customized and syndicated market research reports that help our clients create visionary growth
plans to provide traction to their business. We meticulously study emerging trends across various
industries at both the global and regional levels to identify new opportunities for our clientele. Our global
team of over 100 research analysts and freelance consultants provide market intelligence from the very
molecular country level and also provide a global perspective of the market. Our team is of the most vital
cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive
defusion training module.This allows for an objective and unbiased assessment of the market. We pride
ourselves in my constantly striving to update our extremely in-depth understanding of the market by
closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable
industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize
on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth
path in the future.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel : +1-206-701-6702
Email: [email protected]

Synthetic biology is extensively used in the field of medical and pharmaceuticals to produce and manufacture improved biological drugs and systems to meet various challenges in the healthcare sector.